deferiprone has been researched along with Experimental Radiation Injuries in 3 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Excerpt | Relevance | Reference |
---|---|---|
" Dosing with DFP protected photoreceptors, decreasing the numbers of TUNEL-positive photoreceptors and increasing the number of surviving photoreceptors." | 1.38 | Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina. ( Dunaief, JL; Hadziahmetovic, M; Song, D; Song, Y; Zhong, Y, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Boyd, P | 1 |
Hyde, DR | 1 |
Song, D | 1 |
Song, Y | 1 |
Hadziahmetovic, M | 1 |
Zhong, Y | 1 |
Dunaief, JL | 1 |
Fukuda, S | 1 |
Ikeda, M | 1 |
Anzai, K | 1 |
Suzuki, M | 1 |
Katoh, A | 1 |
Kontoghiorghes, GJ | 1 |
3 other studies available for deferiprone and Experimental Radiation Injuries
Article | Year |
---|---|
Iron contributes to photoreceptor degeneration and Müller glia proliferation in the zebrafish light-treated retina.
Topics: Animals; Animals, Genetically Modified; Apoptosis; Cell Proliferation; Deferiprone; Ependymoglial Ce | 2022 |
Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina.
Topics: Animals; Apoptosis; Deferiprone; Female; Fluorescent Antibody Technique; In Situ Nick-End Labeling; | 2012 |
Radiation protection by deferiprone in animal models.
Topics: Administration, Oral; Animals; Chelating Agents; Chelation Therapy; Deferiprone; Drug Evaluation, Pr | 2006 |